BUPHENYL
sodium phenylbutyrate
- Strength
- 500 mg/1
- Form
- Tablet
- Class
- Nitrogen Binding Agent
Horizon Therapeutics USA, Inc.
Not stocked by us — reference only
sodium phenylbutyrate
Listed by Horizon Therapeutics USA, Inc.
| Dosage form | Powder |
|---|---|
| Route | Oral |
| Drug class | Nitrogen Binding Agent |
| Approval route | NDA — original brand approval |
| NDC code | 75987-070 |
| FDA application | NDA020573 |
| RxNorm concept | 199369 |
| Package sizes listed | 1 |
| Marketed since | April 1996 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
sodium phenylbutyrate
Horizon Therapeutics USA, Inc.
Not stocked by us — reference only
Sodium phenylbutyrate
Medunik USA
Not stocked by us — reference only
GLENMARK PHARMACEUTICALS INC., USA
Not stocked by us — reference only
Navinta LLC
Not stocked by us — reference only
Zydus Pharmaceuticals USA Inc.
Not stocked by us — reference only
Par Health USA, LLC
Not stocked by us — reference only
Sodium Phenylbutyrate Tablets, 500 mg
Par Health USA, LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.